PRETREATMENT WITH NON-DEPOLARIZING NEUROMUSCULAR BLOCKING AGENTS AND SUXAMETHONIUM-INDUCED INCREASES IN RESTING JAW TENSION IN CHILDREN
|
|
- Erick Long
- 6 years ago
- Views:
Transcription
1 British Journal of Anaesthesia 1990; 64: PRETREATMENT WITH NON-DEPOLARIZING NEUROMUSCULAR BLOCKING AGENTS AND SUXAMETHONIUM-INDUCED INCREASES IN RESTING JAW TENSION IN CHILDREN C. E. SMITH, J. M. SADDLER, J. C. BEVAN, F. DONATI AND D. R. BEVAN SUMMARY We have studied the effect of prior administration of non-depolarizing neuromuscular blocking drugs on suxamethonium-induced increases in masseter muscle tension in 21 children aged 3-10 yr, anaesthetized with nitrous oxide and halothane using supramaximal stimulation of the ulnar nerve and the nerve to masseter. Resting tension and isometric force of contraction were measured in the adductor pollicis and masseter muscles. A sub-paralysing dose of tubocurarine 0.05 mg kg' 1, a paralysing dose of atracurium 0.5 mg kg' 1 or saline was given, followed 3 min later by suxamethonium 1 mg kg' 1. Onset times of suxamethonium and atracurium block were shorter in the masseter than in the adductor pollicis muscle. When preceded by a subparalysing dose of tubocurarine. suxamethonium produced an increase in masseter tension (47 (SEM 15) g) similar to that produced by suxamethonium alone (59 (13) g). Prior administration of a paralysing dose of atracurium almost abolished this increase in tension (2.5 (2.5) g) (P < 0.05 vs saline). The tension increase in adductor pollicis was (2.2) and 5.9(1.1) g in the atracurium. tubocurarine and saline groups. respectively. and atracurium prevented muscle fasciculations in all patients. It was concluded that increased muscle tone is a normal response to suxamethonium and is greater in the masseter than adductor pollicis. Sub-paralysing doses ofnon- depolarizing neuromuscular blockers have little effect, in contrast with paralysing doses. This suggests that the effect is mediated via postsynaptic receptors. KEY WORDS Complications: masseter spasm. Neuromuscular relaxants: atracurium, suxamethonium. tubocurarine, drug interactions. The administration of suxamethonium may be associated with masseter muscle rigidity [1], the incidence of which was reported to be 1 % of normal children [2]. Muscle biopsy studies indicate susceptibility to malignant hyperthermia (MH) in 40-60% of these patients [3,4]. Recently, suxamethonium has been reported to cause increased jaw muscle tension in a large proportion of adults [5] and children [6] and reduced mouth opening and increased jaw stiffness in children [7, 8]. The mechanism of action of this phenomenon is unknown. Theoretically, the site could be at the presynaptic receptor, the postsynaptic receptor or the muscle itself. Pretreatment with a nondepolarizing neuromuscular blocker may help in identifying the site of action. When sub-para- CHARLES E. SMITH*, M.D., F.R.C.P.C. ; JOHN M. SADDLER-)-, M.B., F.F.A.R.C.S.; JOAN C. BEVANF, M.D., D.R.C.O.G., F.F.A.R.C.S. ; FRANCOIS DONATIJ, PH.D., M.D., F.R.C.P.C. ; DAVID R. BEVANJ, M.B., M.R.C.P., F.F.A.R.C.S.; Departments of Anaesthesia, Montreal Children's Hospital and Royal Victoria Hospital, McGill University, Montreal, Quebec, Canada. Accepted for Publication: November 3, Present addresses: Department of Cardiothoracic Anaesthesia, Cleveland Clinic Foundation, Cleveland, Ohio, U.S.A. tdepartment of Anaesthesia, Montreal Children's Hospital, 2300 Tupper Street, Montreal, Quebec, Canada. tmcgill Department of Anaesthesia, Royal Victoria Hospital, 687 Pine Avenue West, Montreal, Quebec, Canada H3A 1A1. Correspondence to D.R.B.
2 578 BRITISH JOURNAL OF ANAESTHESIA lysing doses of such agents are used, their prevention of suxamethonium- induced fasciculations is most probably presynaptic in origin [9-11]. Much larger doses of non-depolarizing neuromuscular blocker are required to produce a measurable effect at postsynaptic receptors. This study was undertaken to examine the interactions between suxamethonium and subparalysing and paralysing doses of nondepolarizing blocker, with emphasis on increases in masseter tension. The investigation was conducted in children aged 3-10 yr, a group of patients in whom this effect has been recognized as a normal response to suxamethonium [6]. PATIENTS AND METHODS We studied 21 children, ASA physical status I, aged 310 yr, undergoing elective day-care surgery. Institutional approval and informed parental consent were obtained. Patients with neuromuscular, renal, hepatic or electrolyte disorders, or those taking medications known or thought to interfere with neuromuscular transmission were excluded. Patients with evidence of trigeminal nerve dysfunction, abnormal dentition or mandibular configuration were excluded from the study, as were patients with a history of atypical plasma cholinesterase, masseter rigidity or malignant hyperthermia. No premedicatdon was given. Monitoring included automatic oscillotonometry, electrocardiography, a precordial stethoscope and an oesophageal temperature probe. Anaesthesia was induced with halothane and 66% nitrous oxide in oxygen, or thiopentone 57 mg kg" 1 i.v. Atropine 0.01 mg kg" 1 i.v. was administered, and tracheal intubation was performed under deep halothane anaesthesia without the use of myoneural blockers. Supramaximal train-of-four stimulation was applied to the ulnar nerve at the elbow and to the mandibular branch of the trigeminal nerve inferior to the zygomatic arch, anterior to the mandibular condyle, as described previously [12]. Stimulation of the ulnar nerve resulted in adductor pollicis contraction which was measured with a Grass F-10 force displacement transducer and recorded on paper. Stimulation of the trigeminal nerve resulted in masseter contraction and jaw closure which was measured by a force transducer system attached to both an oral airway and a metal frame fixed to the operating table 10 cm caudad to the chin. Supramaximal train-offour stimulation of the nerve to masseter was assured by progressively increasing the voltage until the jaw response had stabilized. The voltage was then set 15% greater than this value. After stabilization of adductor pollicis and masseter muscle twitch, seven patients in each group received, by random allocation, a sub-paralysing dose of tubocurarine (0.05 mg kg" 1 ), a paralysing dose of atracurium (0.5 mg kg" 1 ), or saline, followed 3 min later by suxamethonium l.omgkg" 1. The time to onset, maximum effect and duration of suxamethoniuminduced changes in masseter and adductor pollicis tensions were measured and compared using Student's t test with Bonferroni correction where applicable. Similarly, the time from injection of suxamethonium to 100% neuromuscular block and 100% recovery were measured at both muscles in the tubocurarine and saline groups. Time from injection of atracurium to 100 % block was measured also. At the end of the study, both adductor pollicis and masseter force transducers were calibrated with known weights. Thus the magnitude of the imposed baseline tension, baseline tension change and control contraction could be determined for both muscles. Results are expressed as mean (SEM). Muscle fasciculations were graded as absent, fine or moderate to vigorous. P < 0.05 was considered to indicate a statistically significant difference. RESULTS The groups were similar with respect to sex, age, weight and height (table I). There were no differences in resting and control twitch tensions between the three groups for each muscle (table II). There was no change in twitch height following tubocurarine or saline. All patients had complete neuromuscular block of both muscles within 1 min following suxamethonium (table III) and within 2 min after atracurium. The onset of neuromuscular block was faster at the masseter than at the adductor pollicis. For atracurium, the time to 100% Tl Sex (M/F) Age (months) Weight (kg) Height (cm) TABLE I. Patient data (mean (SEM)) 6/1 72(7) 22(2) 120 (6) 4/3 70(8) 23(4) 114(6) 5/2 61(8) 20(2) 110 (4)
3 NMB DRUGS AND SUXAMETHONIUM-INDUCED FASCICULATIONS 579 TABLE II. Resting muscle tension and control twitch height (mean (SEM)) Resting tension Control twitch height Resting tension Control twitch height 18(2) 114(14) 102 (26) 455 (56) 30(7) 93(6) 154 (27) 317(47) 34(9) 85 (12) 147(17) 377 (44) TABLE III. Time to 100% depression and recovery of the first twitch of TOF stimulation after suxamethonium (mean (SEM)). * P < 0.05 vs adductor pollicis muscle Onset Recovery Onset Recovery (min) 0.61 (0.07) 4.8 (0.3) 0.44 (0.07)* 4.8 (0.3) (min) 0.69(0.11) 4.9 (0.06) 0.44(0.10)* 5.3 (0.8) depression was 1.0 (0.2) vs 1.6 (0.3) min for masseter and adductor pollicis, respectively (P < 0.05). For suxamethonium, onset times are shown in table III. Suxamethonium did not alter the magnitude of the block in patients who received atracurium. Recovery times after suxamethonium were similar in both muscles. pretreatrnent did not affect either onset or recovery times (table III). All patients in the tubocurarine- and salinetreated groups exhibited increases in masseter and adductor pollicis tension after suxamethonium. The magnitude and time course of these changes were similar. Maximum resting changes occurred during maximal twitch depression. The increase in tension was approximately 10 times as great in the masseter compared with adductor pollicis. However, only one patient pretreated with a paralysing dose of atracurium demonstrated a detectable increase in masseter tension, and none of these patients had any change in adductor pollicis tension (table IV). Five patients, all in the saline group, had muscle fasciculations (two, fine tremor; three, moderate contractions). DISCUSSION The present study demonstrated that, although a sub-paralysing dose of tubocurarine was effective in preventing suxamethonium-induced fasciculations, it was ineffective in reducing changes in baseline muscle tension. However, the changes in masseter and adductor pollicis tension caused by suxamethonium were abolished by a paralysing dose of atracurium. The maximum increase in masseter muscle tone occurred at a time when block of neuromuscular transmission had commenced or was completed. The differences observed between patients pretreated with tubocurarine and atracurium may have been drug induced, but are more likely to have been the result of different doses. was chosen because it is commonly used clinically to prevent fasciculations. The dose used in this study, 0.05 mg kg" 1, equivalent to about 10% of the ED,j [13], produces no detectable TABLE IV. Increases in resting muscle tension after suxamethonium (mean (SEM)). P < 0.05 vs masseter muscle; \ P < 0.05 vs saline and tubocurarine groups Maximal increase Time to onset (min) Duration (min) Maximal increase Time to onset (min) Duration (min) 5.9 (1.1)* 0.29 (0.04) 1.10(0.12) 59 (13) 0.26(0.05) 1.70(0.67) 3.2 (2.2)* 0.25 (0.03) 0.72 (0.25) 47(15) 0.25 (0.07) 1.70(0.70) 0 2.5(2.5)t
4 580 BRITISH JOURNAL OF ANAESTHESIA neuromuscular block but helps in preventing fasriculations [14-18]. None of the patients in this study demonstrated neuromuscular block after administration of this dose. was chosen in the group which received a paralysing dose of non-depolarizing myoneural blocker because the cardiovascular effects and prolonged duration of action of an equipotent dose of tubocurarine would be clinically unacceptable. The dose of atracurium was approximately twice the ED 86 [13] and was probably sufficient to block more than 96% of receptors, while a subparalysing dose of tubocurarine would have blocked fewer than 70% of receptors [19]. Thus the present study indicated that block of the postsynaptic receptors was effective in preventing tension increases produced by suxamethonium. However, a large proportion of receptors must be occupied before the effect is abolished, suggesting that only a few receptors are needed for suxamethonium-induced tension changes. The ineffectiveness of sub-paralysing doses of tubocurarine in preventing tension increases suggests that this effect of suxamethonium is not presynaptic. In animals, only small doses of tubocurarine or vecuronium are required to abolish presynaptic activity [9-11] and fasciculations [9]. Similarly, the changes in muscle tension associated with suxamethonium are unlikely to be the effect of a direct action of suxamethonium on muscle, as a drug which acts at the neuromuscular junction effectively blocks this response. However, it was not possible to determine if the postsynaptic receptors involved are junctional or extrajunctional. The present study supports the contention that increases in muscle tension are a normal response to suxamethonium in both children and adults [5-8]. It also suggests that the masseter is not qualitatively different from other muscles. Changes in tension were found also in the adductor pollicis, supporting previous work [6]. Interestingly, the time course of changes observed after suxamethonium in this study were similar to, although quantitatively less than, those observed previously in patients with myotonia [20]. This suggests that treatment of a myotonic response or masseter muscle rigidity following suxamethonium could perhaps be accomplished by large doses of non-depolarizing blocking drugs. Such abnormal responses may be considered as an exaggerated form of the normal pharmacological effect of suxamethonium [6-8]. The onset of neuromuscular block was more rapid at the masseter than at the adductor pollicis, and this was demonstrated for both suxamethonium and atracurium. Part of this difference might be explained by the greater potency of suxamethonium at the masseter than at the adductor pollicis muscle [6]. However, differences in circulation time and blood flow between the muscles probably explain most of the difference. Pretreatment with tubocurarine did not prolong the onset time or shorten its duration of action, as could have been expected from adult studies [14, 16, 17]. The possibility that children might be different in this regard should be considered. Suxamethonium did not antagonize the nondepolarizing block produced by atracurium. Such antagonism has been described previously for non-depolarizing block in the range % [21-23]. In the present study, however, the block produced by atracurium was probably too intense to be antagonized. This study was performed in patients without evidence of malignant hyperthermia, and extrapolation of these results to responses seen after suxamethonium in that condition may be inappropriate. However, if masseter spasm is an exaggerated form of the normal pharmacological response to suxamethonium, pretreatment with a defasciculating dose of non-depolarizing neuromuscular blocker is unlikely to affect the clinical course. If masseter rigidity is encountered, administration of paralysing doses of nondepolarizing blockers may decrease the response, but this possibility has not been tested independently. Furthermore, this solution might be impossible to apply in clinical practice. spasm is associated usually with inability to secure the airway. In this case, adminstration of a drug which causes prolonged neuromuscular block is not recommended. REFERENCES 1. Donlon JV, Newfield P, Streter I, Ryan JF. Implications of masseter spasm after succinylcholine. Anesthesiology 1978; 49: Schwartz L, Rockoff MA, Koka BV. spasm with anesthesia: Incidence and implications. Anesthesiology 1984; 61: Rosenberg H, Fletcher JE. muscle rigidity and malignant hyperthermia susceptibility. Anesthesia and Analgesia 1986; 65: Rosenberg H, Reed S. In vitro contracture tests for susceptibility to malignant hyperthermia. Anesthesia and Analgesia 1983; 62:
5 NMB DRUGS AND SUXAMETHONIUM-INDUCED FASCICULATIONS Smith CE, Donati F, Bcvan DR. Dose-response relationships of succinylcholine at the masseter and adductor pollids muscle in humans. Anesthesiology 1988; 69: A Plumley MH, Bevan JC, Saddler JM, Donati F, Bevan DR. Succinylcholine and increased resting jaw tension in children. Anesthesia and Analgesia 1989; 68: S Van Der Spek AFL, Fang WB, Ashton-MUler JA, Stohler CS, Carlson DS, Schork MA. The effects of succinylcholine on mouth opening. Anesthesiology 1987; 67: Van Der Spek AFL, Fang WB, Ashton-Miller JA, Stohler CS, Carlson DS, Schork MA. Increased masticatory muscle stiffness during limb muscle flaccidity associated with succinylcholine administration. Anesthesiology 1988; 69: Hartman GS, Fiamengo SA, Riker WF. Succinylcholine: mechanism of fasciculations and their prevention by d-tubocurarine or diphenylhydantoin. Anesthesiology 1986; 65: Baker T, AgueroA, Stance A, LowndesHE. Prejunctional effects of vecuronium in the cat. Anesthesiology 1986; 65: Baker T, Stance A. Drug actions at mammalian motor nerve endings: The suppression of neostigmine-induced fasciculations by vecuronium and isonurane. Anesthesiology 1987; 67: Smith CE, Donati F, Bevan DR. Differential effects of pancuroniurn on masseter and adductor pollicis muscles in humans. Canadian Journal of Anaesthesia 1988: 35: SI Shanks CA. Pharmacokinetics of the non-depolarizing neuromuscular relaxant! applied to calculation of bolus and infusion dosage regimens. Anesthesiology 1986; 64: Miller RD, Way WL. The interaction between succinylcholine and subparalyzing doses of d-tubocurarine and gallamine in man. Anesthesiology 1971; 35: Cullen DJ. The effect of pretreatment with non-depolarizing muscle relazants on the neuromuscular blocking action of succinylcholine. Anesthesiology 1971; 35: Ferguson A, Bevan DR. Mixed neuromuscular block. The effect of precurarization. Anaesthesia 1981; 36: Blitt CD, Carlson GL, Rolling GD, Hameroff SR, Otto CW. A comparative evaluation of pretreatment with nondepolarizing neuromuscular blockers prior to the administration of succinylcholine. Anesthesiology 1981; 55: Horrow JC, Lambert DH. The search for an optimal interval between pretreatment dose of d-tubocurarine and succinylcholine. Canadian Anaesthetists Society Journal 1984; 31: Paton WDM, Waud DR. The margin of safety of neuromuscular transmission. Journal of Physiology (London) 1967; 191: 59-^ Mitchell MM, Ah' HH, Savarese JJ. Myotonia and neuromuscular blocking agents. Anesthesiology 1978; 49: Walts LF, Dillon JB. Clinical studies of the interaction between d-tubocurarine and succinylcholine. Anesthesiology 1969; 31: Buzello W, Krieg N, Kuhls E, Schlickewei A. Modification of pancuronium induced non-depolarizing neuromuscular block by succinylcholine in anesthetized humans. Anesthesiology 1983; 59: Scott RPF, Norman J. Effect of suxamethonium given during recovery from atracurium. British Journal of Anaesthesia 1988; 61:
NERVOUS SYSTEM NERVOUS SYSTEM. Somatic nervous system. Brain Spinal Cord Autonomic nervous system. Sympathetic nervous system
SYNAPTIC NERVOUS SYSTEM NERVOUS SYSTEM CENTRAL NERVOUS SYSTEM PERIPHERAL NERVOUS SYSTEM Brain Spinal Cord Autonomic nervous system Somatic nervous system Sympathetic nervous system Parasympathetic nervous
More informationDETERMINANTS OF THE REVERSAL TIME OF COMPETITIVE NEUROMUSCULAR BLOCK BY ANTICHOLINESTERASES
British Journal of Anaesthesia 1991; 66: 469-45 DETERMINANTS OF THE REVERSAL TIME OF COMPETITIVE NEUROMUSCULAR BLOCK BY ANTICHOLINESTERASES G. H. BEEMER, A. R. BJORKSTEN, P. J. DAWSON, R. J. DAWSON, P.
More informationPOTENTIATION OF THE NEUROMUSCULAR BLOCKADE PRODUCED BY ALCURONIUM WITH HALOTHANE, ENFLURANE AND ISOFLURANE
Br.J. Anaesth. (987), 9, 0-06 POTENTIATION OF THE NEUROMUSCULAR BLOCKADE PRODUCED BY ALCURONIUM WITH HALOTHANE, ENFLURANE AND ISOFLURANE S. J. KEENS, J. M. HUNTER, S. L. SNOWDON AND J. E. UTTING Volatile
More informationNEUROMUSCULAR BLOCKING AGENTS
NEUROMUSCULAR BLOCKING AGENTS Edward JN Ishac, Ph.D. Associate Professor, Pharmacology and Toxicology Smith 742, 828-2127, Email: eishac@vcu.edu Learning Objectives: 1. Understand the physiology of the
More informationNeuromuscular Junction
Muscle Relaxants Neuromuscular Junction Cholinergic antagonists Neuromuscular-blocking agents (mostly nicotinic antagonists): interfere with transmission of efferent impulses to skeletal muscles. These
More informationPOST-TETANIC COUNT AND INTENSE NEUROMUSCULAR BLOCKADE WITH VECURONIUM IN CHILDREN
Br. J. Anaesth. (988), 6, 55-556 POST-TETANIC COUNT AND INTENSE NEUROMUSCULAR BLOCKADE WITH VECURONIUM IN CHILDREN S. A. RIDLEY AND N. BRAUDE Monitoring of profound neuromuscular blockade may be based
More information(PP XI) Dr. Samir Matloob
DRUGS ACTING ON THE CHOLINERGIC SYSTEM AND THE NEUROMUSCULAR BLOCKING DRUGS IV (NICOTINIC ANTAGONISTS) (PP XI) Dr. Samir Matloob Dept. of Pharmacology Baghdad College of Medicine Drugs acting on the cholinergic
More informationA defasciculating dose of d-tubocurarine causes resistance to succinylcholine
538 A defasciculating dose of d-tubocurarine causes resistance to succinylcholine James B. Eisenkraft MO MRCP FFARCS, Melinda L. Mingus io, Andrew Herlich DMI~ MD, W. Jeffrey Book MO FRCPC, Aaron F. Kopman
More informationChapter 18. Skeletal Muscle Relaxants (Neuromuscular Blocking Agents)
Chapter 18 Skeletal Muscle Relaxants (Neuromuscular Blocking Agents) Uses of Neuromuscular Blocking Facilitate intubation Surgery Agents Enhance ventilator synchrony Reduce intracranial pressure (ICP)
More informationEVALUATION OF ATRACURIUM NEUROMUSCULAR BLOCKADE IN PAEDIATRIC PATIENTS WITH BURN INJURY
Br. J. Anaesth. (1988), 60, 450-455 EVALUATION OF ATRACURIUM NEUROMUSCULAR BLOCKADE IN PAEDIATRIC PATIENTS WITH BURN INJURY A. K. MILLS AND J. A. J. MARTYN Depolarizing neuromuscular blocking drugs such
More informationPOST-TETANIC COUNT AND PROFOUND NEUROMUSCULAR BLOCKADE WITH ATRACURIUM INFUSION IN PAEDIATRIC PATIENTS
Br. J. Anaesth. (9), 60, 3-35 POST-TETANIC COUNT AND PROFOUND NEUROMUSCULAR BLOCKADE WITH ATRACURIUM INFUSION IN PAEDIATRIC PATIENTS S. A. RIDLEY AND D. J. HATCH Atracurium degrades rapidly and, because
More informationEFFECT OF STRETCH EXERCISES ON SUXAMETHONIUM INDUCED FASCICULATIONS AND MYALGIA
Br. J. Anaesth. (1987), 59, 596-601 EFFECT OF STRETCH EXERCISES ON SUXAMETHONIUM INDUCED FASCICULATIONS AND MYALGIA D. A. MAGEE AND R. J. S. ROBINSON The speed of onset of blockade and the excellent intubating
More informationBenztropine and trihexyphenidyl: Centrally acting antimuscarinic agents used for treatment of Parkinson disease & extrapyramidal symptoms.
Scopolamine: Tertiary amine plant alkaloid. Produces peripheral effects similar to those of atropine. Unlike atropine, scopolamine has greater action on the CNS (observed at therapeutic doses). It has
More informationPharmacology of the Neuromuscular Junction (NMJ)
Pharmacology of the Neuromuscular Junction (NMJ) Edward JN Ishac, Ph.D. Professor Smith Building, Room 742 eishac@vcu.edu 828 2127 Department of Pharmacology and Toxicology Medical College of Virginia
More informationOnset of action and intubating conditions after administration of rocuronium or mivacurium in children
79 Onset of action and intubating conditions after administration of rocuronium or mivacurium in children Papagiannopoulou Pinelopi, Sfyra Evaggelia, Georgiou Mary, Georgiadou Theodora, Kanakoudis Fotios
More informationMonitoring of neuromuscular block Conor D McGrath BSc(Hons) MB ChB FRCA
Conor D McGrath BSc(Hons) MB ChB FRCA Jennifer M Hunter MB ChB PHD FRCA There is increasing evidence that residual neuromuscular block is common, and also that it may adversely affect patient outcome.
More informationMUSCLE RELAXANTS. Mr. D.Raju, M.pharm, Lecturer
MUSCLE RELAXANTS Mr. D.Raju, M.pharm, Lecturer Muscle Relaxants are classified as: I)Peripherally acting A.Neuromuscular blocking agents:- 1) Depolarizing muscle relaxants. 2) Non-depolarizing muscle relaxants
More informationCholinergic antagonists
Cholinergic antagonists Cholinergic antagonists: They are also called anticholinergic drugs or cholinergic blockers, this group include: 1.Antimuscarinic agents ( atropine, ipratropium, scopolamine) 2.
More informationChapter 18 Neuromuscular Blocking Agents Study Guide and Application Exercise
Chapter 18 Neuromuscular Blocking Agents Study Guide and Application Exercise 1. Read chapter 2. Review objectives (p.305) 3. Review key terms and definitions (p.305) Add: Cholinesterase inhibitor Vagal
More informationPharmacology of neuromuscular blocking drugs
Pharmacology of neuromuscular blocking drugs Jonas Appiah-Ankam MB ChB FRCA Jennifer M Hunter MB ChB PhD FRCA Key points Neuromuscular blocking drugs (NMBDs) act at several sites at the neuromuscular junction,
More informationThe Neuromuscular Effects and Tracheal Intubation Conditions After Small Doses of Succinylcholine
The Neuromuscular Effects and Tracheal Intubation Conditions After Small Doses of Succinylcholine Mohammad I. El-Orbany, MD, Ninos J. Joseph, BS, M. Ramez Salem, MD, and Arthur J. Klowden, MD Department
More information*Author for Correspondence
COMPARATIVE EVALUATION OF ONSET TIME INTUBATING CONDITION JUDGED BY CLINICAL CRITERIA AND HAEMODYNAMIC RESPONSE AFTER THE INTUBATING DOSE OF ROCURONIUM AND VECURONIUM *Namita Gupta 1, Mamta Sharma 2, Pusplata
More informationNeuromuscular Blockers
Neuromuscular Blockers Joanne Leung joanneleung22@hotmail.com Oct 14, 2014 Objectives After this lecture, you should be able to: Describe the physiology of the neuromuscular junction Differentiate the
More informationPharmacology of the Neuromuscular Junction (NMJ)
Pharmacology of the Neuromuscular Junction (NMJ) Edward JN Ishac, Ph.D. Professor Smith Building, Room 742 eishac@vcu.edu 828 2127 Department of Pharmacology and Toxicology Medical College of Virginia
More informationMaterials and Methods
Anesthesiology 2001; 95:96 101 2001 American Society of Anesthesiologists, Inc. Lippincott Williams & Wilkins, Inc. The Corrugator Supercilii, Not the Orbicularis Oculi, Reflects Rocuronium Neuromuscular
More informationFOR REPRESENTATIVE EDUCATION
Neuromuscular Blockade in the ICU NIMBEX Indication 1 NIMBEX (cisatracurium besylate) is indicated as an adjunct to general anesthesia to facilitate tracheal intubation in adults and in pediatric patients
More informationINTRAOCULAR PRESSURE CHANGES DURING RAPID SEQUENCE INDUCTION OF ANAESTHESIA: COMPARISON OF PROPOFOL AND THIOPENTONE IN COMBINATION WITH VECURONIUM
Br. J. Anaesth. (1988), 60, 379-383 INTRAOCULAR PRESSURE CHANGES DURING RAPID SEQUENCE INDUCTION OF ANAESTHESIA: COMPARISON OF PROPOFOL AND THIOPENTONE IN COMBINATION WITH VECURONIUM R. K. MIRAKHUR, W.
More informationEvaluation of intubation condition following administration of rocuronium in comparison to atracurium in paediatric patients
Original Article Evaluation of intubation condition following administration of rocuronium in comparison to atracurium in paediatric Abdul Kuddus Khan 1*, MM Abdul Wadud 2, Azizul Gafur 3, Rafayetullah
More informationPHARMACODYNAMICS OF MIVACURIUM CHLORIDE IN PATIENTS WITH HEPATIC CIRRHOSIS
British Journal of Anaesthesia 1993; 71: 227-231 PHARMACODYNAMICS OF MIVACURIUM CHLORIDE IN PATIENTS WITH HEPATIC CIRRHOSIS J. C. DEVLIN, A. G. HEAD-RAPSON, C. J. R. PARKER AND J. M. HUNTER SUMMARY Ten
More informationWaiting time after nondepolarizing. alter muscle fasciculation response to succinylcholine
26 Waiting time after nondepolarizing relaxants alter muscle fasciculation response to succinylcholine Alfred C. Pinchak PhD PE MD, Charles E. Smith Mo FRCPC, Lee S. Shepard Mo, Louise Patterson CRNA The
More informationComparative evaluation of atracurium dosed on ideal body weight vs. total body weight in morbidly obese patients
British Journal of Clinical Pharmacology DOI:1.1111/j.1365-2125.21.383.x Comparative evaluation of atracurium dosed on ideal body weight vs. total body weight in morbidly obese patients Simone van Kralingen,
More informationDepartment of Anaesthesiology, Sanjay Gandhi Postgraduate Institute of Medical Sciences, Lucknow, India
Indian J Med Res 122, October 2005, pp 319-323 A randomized controlled double blind study on quick intubation regimen using vecuronium priming infusion technique with the use of patient controlled analgesia
More informationControlled Trial of Wound Infiltration with Bupivacaine for Post Operative Pain Relief after Caesarean Section
Bahrain Medical Bulletin, Vol.23, No.2, June 2001 Controlled Trial of Wound Infiltration with Bupivacaine for Post Operative Pain Relief after Caesarean Section Omar Momani, MD, MBBS, JBA* Objective: The
More informationPropofol reduces succinylcholine induced increase of masseter muscle tone
REPORTS OF INVESTIGATION 417 Wolfgang C. Ummenhofer MD, Christoph Kindler MD, Gabriela TschalEr MD, Karl F. Hampl MD, Juergen Drewe MD, Albert Urwyler MD Propofol reduces succinylcholine induced increase
More informationGanglion blocking agents
Ganglion blocking agents -out of date -Specifically act on the nicotinic receptors of both parasymphatetic and sympathetic ganglia - no selectivity toward PG or SG -These drugs are non-depolarizing, competitive
More informationVECURONIUM BROMIDE IN ANAESTHESIA FOR LAPAROSCOPIC STERILIZATION
Br. J. Anaesth. (1985), 57, 765-769 VECURONIUM BROMIDE IN ANAESTHESIA FOR LAPAROSCOPIC STERILIZATION J. E. CALDWELL, J. M. BRAIDWOOD AND D. S. SIMPSON Although artificial ventilation can be used to avoid
More informationTRANSPARENCY COMMITTEE OPINION. 21 January 2009
The legally binding text is the original French version TRANSPARENCY COMMITTEE OPINION 21 January 2009 BRIDION 100 mg/ml, solution for injection Box containing 10 x 2 ml bottles, CIP: 573 553-9 Box containing
More informationINTERACTION OF MIDAZOLAM WITH TWO NON-DEPOLARIZING NEUROMUSCULAR BLOCKING DRUGS IN THE RAT IN VIVO SCIATIC NERVE-TIBIALIS ANTERIOR MUSCLE PREPARATION
Br.J. Anaesth. (1985), 57, 1089-1094 INTERACTION OF MIDAZOLAM WITH TWO NON-DEPOLARIZING NEUROMUSCULAR BLOCKING DRUGS IN THE RAT IN VIVO SCIATIC NERVE-TIBIALIS ANTERIOR MUSCLE PREPARATION J. J. DRIESSEN,
More informationEFFECTS OF POSTURE AND BARICITY ON SPINAL ANAESTHESIA WITH 0.5 % BUPIVACAINE 5 ML
Br.J. Anaesth. (1988), 61, 139-143 EFFECTS OF POSTURE AND BARICITY ON SPINAL ANAESTHESIA WITH 0.5 % BUPIVACAINE 5 ML A Double-Blind Study R. W. D. MITCHELL, G. M. R. BOWLER, D. B. SCOTT AND H. H. EDSTROM
More informationSOME surgeons have been of the opinion for a number of
DOES ETHER AFFECT THE EXTENSIBILITY OR ELASTIC RECOIL OF MUSCLE? By J. D. P. GRAHAM and the late R. ST. A. HEATHCOTE Department of Pharmacology, Welsh National School of Medicine, Cardiff SOME surgeons
More informationINTUBATING CONDITIONS AND INJECTION PAIN
INTUBATING CONDITIONS AND INJECTION PAIN - Cisatracurium or Rocuronium versus Rocuronium-Cisatracurium Combination - AHED ZEIDAN *, NAZIH NAHLE *, HILAL MAALIKI ** AND ANIS BARAKA *** Summary The present
More informationCOMPARISON OF INTUBATING CONDITIONS OF SUCCINYLCHOLINE WITH THAT OF ROCURONIUM
COMPARISON OF INTUBATING CONDITIONS OF SUCCINYLCHOLINE WITH THAT OF ROCURONIUM *Lata D. Shetty Department of Anaesthesiology, Khaja Banda Nawaz Institute of Medical Sciences Gulbarga, Karnataka, India
More informationGanglionic Blocking Agents
Ganglionic Blocking Agents 1- Depolarizing Ganglionic Blocking Agents Depolarizing blocking agents are actually ganglionic stimulants. Thus, for nicotine, small doses give an action similar to that of
More informationThe Neuromuscular Junction: Pharmacologic Applications During Anesthesia
Page 1 The Neuromuscular Junction: Pharmacologic Applications During Anesthesia Cynthia A. Lien, M.D. New York, NewYork Introduction The neuromuscular junction and neuromuscular transmission are well-studied
More informationMUSCLE relaxants are used to provide better operating conditions for
CLEVELAND CLINIC QUARTERLY Copyright 1970 by The Cleveland Clinic Foundation Volume 37, July 1970 Printed in U.S.A. Pancuronium bromide A new non-depolarizing muscle relaxant Preliminary in fifty patients
More informationSevoflurane and isoflurane, but not propofol, decrease mivacurium requirements over time
907 General Anesthesia Sevoflurane and isoflurane, but not propofol, decrease mivacurium requirements over time [Le sévoflurane et l isoflurane, mais pas le propofol, diminuent les besoins en mivacurium
More informationSkeletal Muscle Relaxants. Munir Gharaibeh, MD, PhD, MHPE Faculty of Medicine, The University of Jordan March, 2014
Skeletal Muscle Relaxants Munir Gharaibeh, MD, PhD, MHPE Faculty of Medicine, The University of Jordan March, 2014 The nicotinic Acetycholine receptor Present at the neuromuscular junction, peripheral
More informationTracheal intubation in children after induction of anesthesia with propofol and remifentanil without a muscle relaxant
Original Article Tracheal intubation in children after induction of anesthesia with propofol and remifentanil without a muscle relaxant Mirmohammad Taghi Mortazavi, 1 Masood Parish, 1 Naghi Abedini, 2
More informationMaterials and Methods
Anesthesiology 2002; 97:616 21 2002 American Society of Anesthesiologists, Inc. Lippincott Williams & Wilkins, Inc. Duration of Anesthesia before Muscle Relaxant Injection Influences Level of Paralysis
More informationThe Latest Approaches to Reversal of Neuromuscular Blocking Agents
The Latest Approaches to Reversal of Neuromuscular Blocking Agents Janay Bailey, Pharm.D. Anesthesiology 2017; 126:173-90 Objectives Pharmacists Determine optimal paralytic choices in knowing if reversal
More informationEffect of magnesium sulfate with propofol induction of anesthesia on succinylcholine-induced fasciculations and myalgia
Original Article Effect of magnesium sulfate with propofol induction of anesthesia on succinylcholine-induced fasciculations and myalgia Mahendra Kumar, Nalin Talwar, Ritu Goyal, Usha Shukla, AK Sethi
More informationA. G. HEAD-RAPSON, J. C. DEVLIN, C. J. R. PARKER AND J. M. HUNTER. Summary. British Journal of Anaesthesia 1995; 75: 31 36
British Journal of Anaesthesia 1995; 75: 31 36 Pharmacokinetics and pharmacodynamics of the three isomers of mivacurium in health, in end-stage renal failure and in patients with impaired renal function
More informationComparison of two rocuronium bromide doses in adult and elderly patients who underwent laparoscopic surgery
Comparison of two bromide doses in adult and elderly patients who underwent laparoscopic surgery Passavanti MB, MD Pace MC, MD Sansone P, MD Chiefari M, MD Iannotti M, MD Maisto M, MD Aurilio C, MD Department
More informationPRODUCTION OF LAUDANOSINE FOLLOWING INFUSION OF ATRACURIUM IN MAN AND ITS EFFECTS ON AWAKENING
Br. J. Anaesth. (1989), 63, 76-80 PRODUCTION OF LAUDANOSINE FOLLOWING INFUSION OF ATRACURIUM IN MAN AND ITS EFFECTS ON AWAKENING G. H. BEEMER, A. R. BJORKSTEN, P. J. DAWSON AND D. P. CRANKSHAW The continuous
More informationAnesthesia and Neuromuscular Blockade: A Guide for Hospital Pharmacists. Upon completion of this activity, participants will be better able to:
Anesthesia and Neuromuscular Blockade: A Guide for Hospital Pharmacists EDUCATIONAL OBJECTIVES Upon completion of this activity, participants will be better able to: 1. Understand the use of neuromuscular
More informationR. A. COOPER, V. R. MADDINENI, R. K. MIRAKHUR, J. M. K. H. WIERDA, M. BRADY AND K. T. J. FITZPATRICK. British Journal of Anaesthesia 1993; 71:
British Journal of Anaesthesia 13; 71: 222-226 TIME COURSE OF NEUROMUSCULAR EFFECTS AND PHARMACOKINETICS OF ROCURONIUM BROMIDE (ORG 426) DURING ISOFLURANE ANAESTHESIA IN PATIENTS WITH AND WITHOUT RENAL
More informationXiaochong Fan, Minyu Ma, Zhisong Li, Shengkai Gong, Wei Zhang, Yuanyuan Wen
Int J Clin Exp Med 2015;8(9):16369-16373 www.ijcem.com /ISSN:1940-5901/IJCEM0008198 Original Article The relationship between the target effective site concentration of rocuronium and the degree of recovery
More informationPRE-TREATMENT WITH MAGNESIUM SULPHATE BEFORE NON-DEPOLARIZING MUSCLE RELAXANTS: EFFECT ON SPEED ON ONSET, INDUCTION AND RECOVERY
PRE-TREATMENT WITH MAGNESIUM SULPHATE BEFORE NON-DEPOLARIZING MUSCLE RELAXANTS: EFFECT ON SPEED ON ONSET, INDUCTION AND RECOVERY Suresh Singh 1, Deepak Malviya 2, Sujeet Rai 1, Birendra Yadav 3, Sanjeev
More informationCLINICAL ASSESSMENT OF NEUROMUSCULAR TRANSMISSION
Br. J. Anaesth. (1982), 54, 209 CLINICAL ASSESSMENT OF NEUROMUSCULAR TRANSMISSION J. VIBY-MOGENSEN Traditionally, the degree of neuromuscular blockade during and after anaesthesia is evaluated solely on
More informationPRODUCT INFORMATION CISATRACURIUM PFIZER NAME OF THE MEDICINE DESCRIPTION PHARMACOLOGY. Cisatracurium besylate
PRODUCT INFORMATION CISATRACURIUM PFIZER Cisatracurium besylate NAME OF THE MEDICINE The chemical name of cisatracurium besylate is (1R,1 R,2R,2 R,)-2,2 -(3,11-dioxo-4,10- dioxatridecamethylene) bis (1,2,3,4-tetrahydro-6,7-dimethoxy-2-methyl-1-
More informationEffect of Magnesium Sulphate on the Speed of Onset and Duration of Neuromuscular Block Produced by Rocuronium Bromide
IOSR Journal of Dental and Medical Sciences (IOSR-JDMS) e-issn: 2279-0853, p-issn: 2279-0861.Volume 16, Issue 2 Ver. VI (February. 2017), PP 54-58 www.iosrjournals.org Effect of Magnesium Sulphate on the
More informationThis drug should be administered only by adequately trained individuals familiar with its actions, characteristics, and hazards.
MIVACRON Injection (mivacurium chloride) This drug should be administered only by adequately trained individuals familiar with its actions, characteristics, and hazards. DESCRIPTION MIVACRON (mivacurium
More informationThe use of a muscle relaxant to supplement local anaesthetics for Bier's
Archives of mergency Medicine, 1988, 5, 79-85 The use of a muscle relaxant to supplement local anaesthetics for Bier's blocks R. McGLON,1 F. HYS2 & P. HARRIS3 'The General Infirmary, Leeds, 2Accident and
More informationAnaesthesia pearls and pitfalls in periodic paralysis
Biannual Meeting of the PPA Orlando, FL, 2013 Anaesthesia pearls and pitfalls in periodic paralysis Department of Neurology Military Hospital Ulm Germany Frank Weber Frank Lehmann Horn, Senior Research
More informationCover Page. The handle holds various files of this Leiden University dissertation
Cover Page The handle http://hdl.handle.net/1887/37228 holds various files of this Leiden University dissertation Author: Mirzakhani, Hooman Title: The role of clinical pharmacology and pharmacogenetics
More informationEVALUATION OF ATRACURIUM BESYLATE AND VECURONIUM BROMIDE IN COMBINATION TO FACILITATE RAPID TRACHEAL INTUBATION
Original Article EVALUATION OF ATRACURIUM BESYLATE AND VECURONIUM BROMIDE IN COMBINATION TO FACILITATE RAPID TRACHEAL INTUBATION Kiran B Patel 1, Ananyaruchi S Sharma 2, Hitesh S Patel 2, Rahul D Patel
More informationThe effect of desflurane on rocuronium onset, clinical duration and maintenance requirements
(Acta Anaesth. Belg., 2006, 57, 349-353) The effect of desflurane on rocuronium onset, clinical duration and maintenance requirements R. G. STOUT (*), T. J. GAN (**), P. S. A. GLASS (***), D. G. SILVERMAN
More information2003 American Society of Anesthesiologists, Inc. Lippincott Williams & Wilkins, Inc.
CLINICAL INVESTIGATIONS Anesthesiology 2003; 98:1042 8 2003 American Society of Anesthesiologists, Inc. Lippincott Williams & Wilkins, Inc. Residual Paralysis in the PACU after a Single Intubating Dose
More informationLESSON ASSIGNMENT. LESSON OBJECTIVES 3-1. Given a group of definitions, select the definition of the term muscle relaxant.
LESSON ASSIGNMENT LESSON 3 Skeletal Muscle Relaxants. TEXT ASSIGNMENT Paragraphs 3-1 through 3-7. LESSON OBJECTIVES 3-1. Given a group of definitions, select the definition of the term muscle relaxant.
More informationNeuromuscular Monitoring and Patient Safety:
Neuromuscular Monitoring and Patient Safety: Pulmonary Complications of Residual Block CEEA Course Tuesday, Sept 4, 2012 Târgu Mureş, Romania Sorin J. Brull, MD, FCARCSI (Hon) Editor, Patient Safety Section
More informationThe optimal succinylcholine dose for intubating emergency patients: retrospective comparative study
æresearch ARTICLE The optimal succinylcholine dose for intubating emergency patients: retrospective comparative study Alaa Ezzat 1 *, Essam Fathi 1, Ahmad Zarour 2, Rajvir Singh 3, M. Osama Abusaeda 4
More information200 mg/20 ml (10 mg/ml) in single-dose vials (3)
HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use NIMBEX safely and effectively. See full prescribing information for NIMBEX. NIMBEX (cisatracurium
More informationEVALUATION OF INTUBATING CONDITIONS WITH AND WITHOUT PRIMING DOSE OF ROCURONIUM BROMIDE
EVALUATION OF INTUBATING CONDITIONS WITH AND WITHOUT PRIMING DOSE OF ROCURONIUM BROMIDE Revathy Jeevarathnam 1, Balasubramaniam Solaiappan 2 1Professor, Department of Anaesthesiology, Chengalpattu Medical
More informationHST-151 Clinical Pharmacology in the Operating Room
Harvard-MIT Division of Health Sciences and Technology HST.151: Principles of Pharmocology Instructors: Dr. Carl Rosow, Dr. David Standaert and Prof. Gary Strichartz 1 HST-151 Clinical Pharmacology in
More informationBritish Journal ofanaesthesia 85 (2): (2000)
British Journal ofanaesthesia 85 (2): 251-5 (2000) Comparison of succinylcholine with two doses of rocuronium using a new method of monitoring neuromuscular block at the laryngeal muscles by surface laryngeal
More informationNeuromuscular blockade in infants following intramuscular succinylcholine in two or five per cent concentration
342 Gordon A. Sutherland MD CH B FFARCS, Joan C. Bevan DROCG FFARCS MD, David R. Bevan Ma MRCP rfartcs Neuromuscular blockade in infants following intramuscular succinylcholine in two or five per cent
More informationNIMBEX (cisatracurium besylate) injection
NIMBEX (cisatracurium besylate) injection This drug should be administered only by adequately trained individuals familiar with its actions, characteristics, and hazards. NOT FOR USE IN NEONATES CONTAINS
More informationNIMBEX Injection. This information is intended for U.S. residents only. only. (cisatracurium besylate)
This information is intended for U.S. residents only. NIMBEX Injection (cisatracurium besylate) only DESCRIPTION CLINICAL PHARMACOLOGY INDICATIONS AND USAGE CONTRAINDICATIONS WARNINGS PRECAUTIONS ADVERSE
More informationComparison of integrated. between the hypothenar and facial muscle groups following atracurium and vecuronium administration
318 Comparison of integrated evoked EMG between the hypothenar and facial muscle groups following atracurium and vecuronium administration M.D. Sharpe MD, C.A. Moote MD, A.M. Lam MO, P.H. Manninen MD In
More informationComparative study of intubating conditions after Rocuronium and Suxamethonium (study of 80 cases)
ISPUB.COM The Internet Journal of Anesthesiology Volume 20 Number 1 Comparative study of intubating conditions after Rocuronium and Suxamethonium (study of 80 cases) K Bhati, V Parmar Citation K Bhati,
More informationDose Response of Succinylcholine at the Adductor Pollicis of Children with Cerebral Palsy During Propofol and Nitrous Oxide Anesthesia
PEDIATRIC ANESTHESIA SECTION EDITOR PAUL R. HICKEY Dose Response of Succinylcholine at the Adductor Pollicis of Children with Cerebral Palsy During Propofol and Nitrous Oxide Anesthesia Mary C. Theroux,
More informationEFFECT OF IONIZED CALCIUM ON THE NEUROMUSCULAR BLOCKING ACTIONS OF ATRACURIUM AND VECURONIUM IN THE CAT
British Journal of Anaesthesia 199; 64: 199-26 EFFECT OF IONIZED CALCIUM ON THE NEUROMUSCULAR BLOCKING ACTIONS OF ATRACURIUM AND VECURONIUM IN THE CAT L. GRAMSTAD AND E. S. HYSING SUMMARY We have determined
More informationThe cholinesterase inhibitors, neostigmine and edrophonium,
Reversal of Rocuronium-Induced Neuromuscular Blockade: A Comparison with Glycopyrrolate and Atropine Ozlem Sacan, MD Paul F. White, MD, PhD Burcu Tufanogullari, MD Kevin Klein, MD BACKGROUND: is a modified
More informationThe Effect of Intraoperative Magnesium Sulphate Infusion on The Course of Neuromuscular Blockade of Atracurium
Journal of the Egyptian Nat. Cancer Inst., Vol. 14, No. 2, June: 137144, 2002 The Effect of Intraoperative Magnesium Sulphate Infusion on The Course of Neuromuscular Blockade of Atracurium NIVIN FAHMY
More informationSuccinylcholine born 1951 and still going faster. Matthias W. König, MD FAAP
Succinylcholine born 1951 and still going faster Matthias W. König, MD FAAP What kind of quack is he? Dr. Lupa never does this! OMG, you want to give SUX? I hope I don t get this question on the oral boards
More informationClinical Evaluation of Isoflurane DEMOGRAPHY OF PATIENT POPULATION JAMES B. FORREST
Clinical Evaluation of Isoflurane DEMOGRAPHY OF PATIENT POPULATION JAMES B. FORREST SINCE THE AIM of the clinical evaluation of isoflurane was to assess its efficacy and safety in a wide spectrum of clinical
More informationThe dose response effect of long-acting nondepolarizing neuromuscular blocking agents in children
246 Nishan G. Goudsouzian Mo, Jeevendra J.A. Martyn MD, Letty M.P. Liu MO, Hassan H. All MI~ The dose response effect of long-acting nondepolarizing neuromuscular blocking agents in children Cumulative
More informationDifferent priming techniques, including mivacurium, accelerate the onset of rocuronium Mohamed Naguib MB BCh MSc FFARCSI MD
902 Different priming techniques, including mivacurium, accelerate the onset of rocuronium Mohamed Naguib MB BCh MSc FFARCSI MD Different priming sequences of equipotent doses of rocuronium and mivacurium
More informationCHAPTER 11. General and Local Anesthetics. Anesthetics. Anesthesia. Eliza Rivera-Mitu, RN, MSN NDEG 26 A
CHAPTER 11 General and Local Anesthetics Eliza Rivera-Mitu, RN, MSN NDEG 26 A Anesthetics Agents that depress the central nervous system (CNS) Depression of consciousness Loss of responsiveness to sensory
More informationComparative study of Succinylcholine, Rocuronium and Vecuronium for intubation and hemodynamic changes during general anaesthesia
IOSR Journal of Dental and Medical Sciences (IOSR-JDMS) e-issn: 2279-0853, p-issn: 2279-0861.Volume 15, Issue 10 Ver. I (October. 2016), PP 14-19 www.iosrjournals.org Comparative study of Succinylcholine,
More informationDYSTROPHIA MYOTONICA AND ATRACURIUM
Br.J. Anaesth. (1985), 57, 1131-1135 DYSTROPHIA MYOTONICA AND ATRACURIUM A Case Report P. NIGHTINGALE, T. E. J. HEALY AND K. McGUINNESS Dystrophia myotonica is the most serious and the most common of the
More informationNeuromuscular Efficacy and Histamine-Release Hemodynamic Changes Produced by Rocuronium versus Atracurium: A Comparative Study
Journal of the Egyptian Nat. Cancer Inst., Vol. 16, No. 2, June: 17-113, 24 Neuromuscular Efficacy and Histamine-Release Hemodynamic Changes Produced by Rocuronium versus Atracurium: A Comparative Study
More informationPRESCRIBING INFORMATION QUELICIN. Neuromuscular Blocking Agent
PRESCRIBING INFORMATION QUELICIN Succinylcholine Chloride Injection USP Neuromuscular Blocking Agent Pfizer Canada Inc. 17300 Trans-Canada Highway Kirkland, Québec H9J 2M5 DATE OF REVISION: June 23, 2017
More informationreceptors determines clinical symptoms of the patients and modulates the sensitivity to nondepolarizing neuromuscular
346 Anesthesiology 2000; 93:346 50 2000 American Society of Anesthesiologists, Inc. Lippincott Williams & Wilkins, Inc. Preanesthetic Train-of-four Fade Predicts the Atracurium Requirement of Myasthenia
More informationCOMPARISON OF IN VITRO CONTRACTURE TESTING WITH RYANODINE, HALOTHANE AND CAFFEINE IN MALIGNANT HYPERTHERMIA AND OTHER NEUROMUSCULAR DISORDERS
British Journal of Anaesthesia 99; 7: 97- COMPARISON OF IN VITRO CONTRACTURE TESTING WITH RYANODINE, HALOTHANE AND CAFFEINE IN MALIGNANT HYPERTHERMIA AND OTHER NEUROMUSCULAR DISORDERS P. M. HOPKINS, F.
More informationInfluence of muscle relaxation on neuromonitoring of the recurrent laryngeal nerve during thyroid surgery
British Journal of Anaesthesia 94 (5): 596 600 (2005) doi:10.1093/bja/aei110 Advance Access publication February 25, 2005 Influence of muscle relaxation on neuromonitoring of the recurrent laryngeal nerve
More informationPLASMA FENTANYL CONCENTRATIONS DURING TRANSDERMAL DELIVERY OF FENTANYL TO SURGICAL PATIENTS
Br. J. Anaesth. (988), 6, 64-68 PLASMA FENTANYL CONCENTRATIONS DURING TRANSDERMAL DELIVERY OF FENTANYL TO SURGICAL PATIENTS D. J. R. DUTHIE, D. J. ROWBOTHAM, R. WYLD, P. D. HENDERSON AND W. S. NIMMO Pain
More informationCISATRACURIUM IN CARDIAC SURGERY
CISATRACURIUM IN CARDIAC SURGERY - Continuous Infusion vs. Bolus Administration - MOOSA MIRINEJAD *, RASOUL AZARFARIN * AND AZIN ALIZADEH ASL * Abstract The aim of this study was the comparison of infusion
More information"Priming" with neostigmine: accelerate reversal of single twitch and trainof-four
30 Francois Donati PH D MD FRCPC, Charles E. Smith MD FRCPC, Saul Wiesel MD, David R. Bevan MB MRCP FFARCS "Priming" with neostigmine: failure to accelerate reversal of single twitch and trainof-four responses
More informationNeuromuscular blocking characteristics of rocuronium bromide mixed with sodium bicarbonate
International Journal of Advances in Health Sciences (IJHS) ISSN 2349-7033 Vol 3, Issue 3, 2016, pp200-207 http://www.ijhsonline.com Research Article Neuromuscular blocking characteristics of rocuronium
More information